*KBW raises price target to $43 from $37; rating market perform. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
NEW YORK, May 3- The New York and Delaware attorneys general and the U.S. housing regulator on Friday dropped their objections to Bank of America Corp's proposed $8.5 billion settlement with investors in Countrywide mortgage-backed securities, according to court filings.
NEW YORK, May 3- The New York and Delaware attorneys general and the U.S. housing regulator on Friday dropped their objections to Bank of America Corp's proposed $8.5 billion settlement with investors in Countrywide mortgage-backed securities, according to court filings.
*Announces offering of medium-term notes of up to $1 billion- SEC filing.
**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
NEW YORK, May 3- The Federal Housing Finance Agency on Friday withdrew its conditional objection to Bank of America Corp's proposed $8.5 billion settlement with investors in Countrywide mortgage-backed securities. Countrywide was acquired by Bank of America in 2008..
**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
**RADCOM LTD, $4.05, up 53 pct. **LINKEDIN CORP, $181.69, down 10 pct. The U.S. Justice Department is suing the company and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.
**LINKEDIN CORP, $186.46, down 8 pct. **VIVUS INC, $13.28, up 3 pct. Arena said on Thursday that it pulled its application seeking approval for its anti-obesity treatment Belviq in the European Union, lowering competition for rival Vivus, whose obesity pill was recommended for European approval by regulators late last month.
**LINKEDIN CORP, $186.46, down 8 pct. **VIVUS INC, $13.28, up 3 pct. Arena said on Thursday that it pulled its application seeking approval for its anti-obesity treatment Belviq in the European Union, lowering competition for rival Vivus, whose obesity pill was recommended for European approval by regulators late last month.
*S&P Capital IQ raises target price by $5 to $50; rating buy. For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on RCH/US Reuters 3000 Xtra users, double-click RCH/US Reuters Station users, click. 1568.
**LINKEDIN CORP, Thursday close $201.67, down 9 pct premarket. **VIVUS INC, Thursday close $12.95, up 4 pct premarket.
*Eldorado Gold Corp posted a first-quarter loss on Thursday, hit by $125.2 million charge related to a change in the Greek tax rate. *Fairfax Financial Holdings Ltd, run by investment guru Prem Watsa, unexpectedly rebounded to a profit in the first quarter, helped by strong underwriting results and investment gains.
**JPMORGAN CHASE& CO, Thursday close $48.08. U.S. government investigators have found that the company had manipulated trading in the California and Michigan electricity markets, the New York Times reported. **LINKEDIN CORP, Thursday close $201.67, down 10 pct after market.
**RADCOM LTD, $4.05, up 53 pct. **LINKEDIN CORP, $181.69, down 10 pct. The U.S. Justice Department is suing the company and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.
*Barclays raises target price to $41 from $36; rating equalweight. Reuters Station users, click. 1568. Reuters Station users, click. 4899.